HealthQuill Articles by: HealthQuill
Dementia patients are diagnosed on average 3.5 years after symptoms are first noticed, and it takes an even longer time for patients with early-onset of the disease, a global study by researchers at the University College London finds.
Health Medical Research

Dementia diagnosis takes 3.5 years after first symptoms surface: UCL study

HQ Team July 29, 2025: Dementia patients are diagnosed on average 3.5 years after symptoms are first noticed, and it takes an even

Read More
The US Food and Drug Administration cleared PTC Therapeutics’ sepiapterin for treating children and adults with a rare genetic condition where the body cannot break down a part of protein called phenylalanine, which comes from foods like meat, eggs, and milk.
Drugs Health Pharma

US regulator clears PTC’s medicine to treat a rare genetic metabolic disease 

HQ Team July 29, 2025: The US Food and Drug Administration cleared PTC Therapeutics’ sepiapterin for treating children and adults with a rare

Read More
Britain’s GSK Plc will pay Jiangsu Hengrui Pharmaceuticals $500 million upfront to acquire global licensing rights for the Chinese company’s 12 potential medicines.
Drugs Health Pharma

GSK inks $500m deal with Jiangsu Hengrui for 12 potential medicines

HQ Team July 28, 2025: Britain’s GSK Plc will pay Jiangsu Hengrui Pharmaceuticals $500 million upfront to acquire global licensing rights for the

Read More
Dopamine rush, brain’s mirror games may help ‘you become what you think’
Health Medical Opinion

Brain’s mirror games may help ‘you become what you think’

By Aparna S. July 28, 2025: Phrases like ‘thoughts become things’ and ‘you become what you think’ are catchy slogans popularised by many motivational

Read More
At least 24 children under the age of five died of malnutrition this month in the conflict-ridden Gaza Strip, taking the overall total of such deaths to 63 in July, according to the World Health Organization.
Drugs Health Medical

Malnutrition claims lives of 24 children in Gaza Strip, hospital cases surge

HQ Team July 28, 2025: At least 24 children under the age of five died of malnutrition this month in the conflict-ridden Gaza

Read More
Vicebio will receive potential milestone payments of up to $450 million based on development and regulatory achievements.
Drugs Health Pharma

Sanofi to acquire UK’s Vicebio for $1.6b, to pocket vaccine candidates

 HQ Team July 22, 2025: Sanofi SA will acquire UK-based Vicebio Ltd. for $1.6 billion to gain access to vaccine candidates for respiratory

Read More
Swedish-British AstraZeneca Plc. plans to build a new facility in the US to manufacture drug components for weight management and metabolism, and invest $50 billion in the country over five years.
Drugs Health Pharma

AstraZeneca to invest $50 billion in US, to build new drug facility

HQ Team July 22, 2025: Swedish-British AstraZeneca Plc. plans to build a new facility in the US to manufacture drug components for weight

Read More
AstraZeneca Plc’s therapy for a certain type of advanced lung cancer, in combination with chemotherapy, helped patients live longer, company data from an end-stage study reveals.
Drugs Health Pharma

AstraZeneca’s therapy for a type of lung cancer helps patients live longer 

HQ Team July 21, 2025: AstraZeneca Plc’s therapy for a certain type of advanced lung cancer, in combination with chemotherapy, helped patients live

Read More
Artificial intelligence platforms for psychiatric patients are showing a pattern of racial bias by proposing different treatments for people of colour, a small Cedars-Sinai study finds.
Health Medical Research

AI platforms for psychiatric patients show racial bias: Cedars-Sinai

HQ Team July 17, 2025: Artificial intelligence platforms for psychiatric patients are showing a pattern of racial bias by proposing different treatments for

Read More
AstraZeneca Plc’s investigational drug to treat AL amyloidosis, a rare and serious disease affecting the heart and kidneys, failed to meet its main goal of helping people to live longer.
Drugs Health Pharma

AstraZeneca’s trial drug for AL amyloidosis fails to meet survival goal

HQ Team July 16, 2025: AstraZeneca Plc’s investigational drug to treat AL amyloidosis, a rare and serious disease affecting the heart and kidneys,

Read More